Development of insulin resistance and its relation to diet in the obese child

Ramón Cañete1, Mercedes Gil-Campos, Concepción M Aguilera

  • 1Unit of Paediatric Endocrinology, Reina Sofia University Hospital, Cordoba, Spain.

Insights

Childhood obesity is rising, with many obese children showing insulin resistance (IR). Dietary factors and hormonal changes from adipose tissue significantly contribute to the development of IR in youth.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome
  • Nutritional Science

Background:

  • Global rise in youth obesity rates.
  • Approximately 30% of obese children exhibit insulin resistance (IR) and metabolic abnormalities.
  • IR in childhood obesity is a growing public health concern.

Purpose of the Study:

  • To review mechanisms of IR development in obese children.
  • To explore links between IR and dietary factors in pediatric and adolescent populations.
  • To update understanding of IR pathogenesis in youth.

Main Methods:

  • Literature review of studies on childhood obesity and IR.
  • Analysis of endocrine and metabolic pathways involved in IR.
  • Examination of dietary influences on adiposity and IR.

Main Results:

  • Increased plasma free fatty acids (FFA) and intracellular LC acyl-CoA are linked to early IR.
  • A new endocrine paradigm highlights adipose tissue hormones and cytokines regulating lipid metabolism, preceding metabolite changes.
  • Excessive caloric intake exacerbates IR; hypocaloric diets reduce it.
  • Dietary factors like high animal protein, saturated/trans/n-6 fats, high carb-to-fat ratio, high glycemic, and low-fiber diets worsen adiposity and IR.

Conclusions:

  • Adipose tissue endocrine dysfunction plays a crucial role in early IR development in obese children.
  • Dietary patterns significantly influence the onset and progression of IR in youth.
  • Interventions targeting caloric intake and diet composition are vital for managing childhood IR.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...